HomeAbout usHospitalsSearchLogin
Your medical data, safe and secure.
Name
Enzalutamide
Description
Enzalutamide is an androgen receptor inhibitor for the treatment of castration-resistant prostate cancer. FDA approved on August 31, 2012.
No brand information found.
